期刊文献+

胃癌患者术前贫血与术后并发症及预后的相关性 被引量:19

Correlation between pre-operative anemia and postoperative complications and prognosis in gastric cancer patients
下载PDF
导出
摘要 目的:探讨术前贫血和贫血程度与胃癌并发症及预后的关系。方法:对2008年10月至2016年11月期间空军军医大学西京医院消化外科3692例行胃癌根治术患者的临床资料进行分析。探索术前贫血和贫血程度对胃癌术后并发症和预后的影响。结果:3692例患者中,男性2889例(78.3%),女性803例(21.7%)。贫血患者1493例(40.4%),年龄20~86岁,中位年龄58.5岁。术前贫血组年龄、性别、肿瘤部位、肿瘤大小、分化程度和T分期、N分期、TNM分期与术前未贫血组存在显著差异(P<0.05)。术前贫血组患者术后发热的发生率明显增高(P<0.05)。单因素分析结果显示,年龄、肿瘤大小、分化程度、T分期、N分期、TNM分期、术前贫血是影响胃癌预后的危险因素(P<0.05)。多因素分析结果显示,术前贫血是影响胃癌预后的独立危险因素(HR=1.141,95%CI:1.018~1.280,P=0.024)。在术前贫血组内,轻度、中度、重度贫血患者的生存无明显差异。结论:胃癌患者术前贫血会增加术后发热的发生率,术前贫血是影响胃癌预后的独立危险因素。 Objective:To analyze the association between pre-operative anemia and degree of anemia with the postoperative complications and prognosis of gastric cancer.Methods:From October 2008 to November 2016,3692 gastric cancer patients treated with radicalgastrectomy were enrolled in the present study.The association betweenpre-operative anemia and degree of anemia with postoperative complications and prognosis of gastric cancer and survival of patients were analysed.Results:There were 2889 males(78.3%)and 803 females(21.7%).The median age was 58.5 years(range 20~86 years old).The anemia group included 1493 patients(40.4%).Age,gender,tumor location,tumor size,differentiation status,T stage,N stage and TNM stage showed statistically significant differences between the anemia group and the non-anemia group(all P<0.05).The anemia group was associated with increased postoperative fever(P<0.05).Univariate analysis showed that age,tumor size,differentiation status,T stage,N stage,TNM stage and pre-operative anemia were risk factors for the prognosis of patients(all P<0.05).Multivariateanalysis showed that pre-operative anemia was independently associated with poor prognosis of patients(HR=1.141,95%CI:1.018~1.280,P=0.024).Conclusion:Pre-operative anemia was associated with postoperative fever.Pre-operative anemia was associated with poor prognosis of gastric cancer patients.
作者 张文明 陆春雷 李科军 刘书尚 丰帆 郭曼 张洪伟 ZHANG Wenming;LU Chunlei;LI Kejun;LIU Shushang;FENG Fan;GUO Man;ZHANG Hongwei(Department of Digestive Surgery,Xijing Hospital,the Air Force Military Medical University,Shaanxi Xi'an 710032,China;Department of General Surgery,Linxia People's Hospital,Gansu Linxia 731100,China;Center of Digestive Disease,Wuxi Mingci Hospital,Jiangsu Wuxi 214000,China)
出处 《现代肿瘤医学》 CAS 北大核心 2021年第7期1183-1187,共5页 Journal of Modern Oncology
基金 国家自然科学基金(编号:81772937,81672742)。
关键词 胃癌 贫血 预后 并发症 gastric cancer anemia prognosis complications
  • 相关文献

参考文献4

二级参考文献42

  • 1郭峰,刘小平,徐瑛.天花粉对小鼠艾氏腹水癌的疗效和对红细胞免疫功能的影响[J].中西医结合杂志,1989,9(7):418-420. 被引量:23
  • 2郭峰 虞紫茜.红细胞免疫功能的初步研究[J].中华医学杂志,1982,62:715-717.
  • 3Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2) :69-90.
  • 4He J, Chen WQ. Chinese Cancer Registry Annual Report 2012 [M]. Beijing:Press of Military Medical Sciences, 2012.
  • 5McGhan LJ, Pockaj BA, Gray RJ,et al. Validation of the upda- ted 7th edition AJCC TNM staging criteria for gastric adenocar- cinoma[J]. J Gastrointest Surg,2012, 16(1):53-61.
  • 6Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophag- eal junction cancer (TOGA) .a phase 3, open-label, randomized controlled trial[J]. Lancet,2010, 376(9742) :687-697.
  • 7Park SH, Lee J, Lee SH, et al. Anemia is the strongest prog- nostic factor for outcomes of 5-fluorouracil-based first-line chem- otherapy in patients with advanced gastric cancer[J]. Cancer Chemother Pharmacol, 2006, 57 (1) : 91-96.
  • 8Lee J, Lim T, Uhm JE, et al. Prognostic model to predict sur- vival following first-line chemotherapy in patients with metastat- ic gastric adenocarcinoma[J]. Ann Oncol, 2007, 18 (5): 886- 891.
  • 9Catalano V, Graziano F, Santini D, et al. Second-line chemo- therapy for patients with advanced gastric cancer:who may bene- fit? [J]. Br J Cancer,2008, 99(9) :1402-1407.
  • 10Kanagavel D, Pokataev IA, Fedyanin MY, et al. A prognostic model in patients treated for metastatic gastric cancer with sec- ond-line chemotherapy[J].Ann Oncol,2010, 21(9):1779-1785.

共引文献67

同被引文献140

引证文献19

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部